Dr Gregory Alan Compton, MD - Medicare Internal Medicine in Charleston, SC

Dr Gregory Alan Compton, MD is a medicare enrolled "Internal Medicine - Hospice And Palliative Medicine" physician in Charleston, South Carolina. He went to Howard University College Of Medicine and graduated in 1976 and has 48 years of diverse experience with area of expertise as Internal Medicine. He is a member of the group practice University Medical Associates Of The Medical University Of South Carol and his current practice location is 171 Ashley Ave, Charleston, South Carolina. You can reach out to his office (for appointments etc.) via phone at (843) 792-1414.

Dr Gregory Alan Compton is licensed to practice in South Carolina (license number 31823) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1093881294.

Contact Information

Dr Gregory Alan Compton, MD
171 Ashley Ave,
Charleston, SC 29425-6221
(843) 792-1414
Not Available



Physician's Profile

Full NameDr Gregory Alan Compton
GenderMale
SpecialityInternal Medicine
Experience48 Years
Location171 Ashley Ave, Charleston, South Carolina
Accepts Medicare AssignmentsYes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.
  Medical Education and Training:
  • Dr Gregory Alan Compton attended and graduated from Howard University College Of Medicine in 1976
  NPI Data:
  • NPI Number: 1093881294
  • Provider Enumeration Date: 11/28/2006
  • Last Update Date: 03/02/2022
  Medicare PECOS Information:
  • PECOS PAC ID: 7214011311
  • Enrollment ID: I20100105000220

Medical Identifiers

Medical identifiers for Dr Gregory Alan Compton such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1093881294NPI-NPPES
77243-1400MedicaidMD
P00851423OtherSCRR MEDICARE PTAN

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
207RG0300XInternal Medicine - Geriatric Medicine 31823 (South Carolina)Secondary
207RH0002XInternal Medicine - Hospice And Palliative Medicine 31823 (South Carolina)Primary
207RG0300XInternal Medicine - Geriatric Medicine D024942 (Maryland)Secondary

Medical Facilities Affiliation

Facility NameLocationFacility Type
Musc Medical CenterCharleston, SCHospital

Group Practice Association

Group Practice NameGroup PECOS PAC IDNo. of Members
University Medical Associates Of The Medical University Of South Carol63057585741297

News Archive

Columbia Laboratories' Board of Directors set a ratio of 1-for-8 for its reverse stock split

Columbia Laboratories, Inc. ("Columbia" or the "Company") (NasdaqCM: CBRX) announced today that its Board of Directors (the "Board") has set a ratio of 1-for-8 for its previously approved reverse stock split of its common stock, and an anticipated effective date for the reverse stock split of the later of (i) the filing with the Secretary of the State of Delaware of a certificate of amendment with respect to the reverse stock split or (ii) August 9, 2013.

Sony Corporation, Global Fund enter into partnership to implement behavior change projects

"Sony Corporation and the Global Fund to Fight AIDS, Tuberculosis and Malaria have entered into a partnership for the implementation of behavior change projects, in which Sony provides state of the art equipment and movies and the Global Fund ensures it gets to agencies best able to reach communities most in need," a Global Fund press release states, noting, "This partnership is the first pilot case that combines pro bono and in-kind contribution."

Research consortium to receive 5.1 million euros to develop new device for breast cancer diagnosis

A large European research consortium headed by the University of Twente is to receive grants of more than five million euros, predominantly from the EU, to develop a new imaging device for the diagnosis of breast cancer.

Using molecular biomarkers to guide the choice of therapies for metastatic pancreatic cancer

A new pilot study demonstrated the feasibility of using molecular tumor markers as the basis for selecting the chemotherapeutic agents to use in patients with metastatic pancreatic cancer.

Allergy Centre of the Charité-Universitätsmedizin Berlin to host three international scientific conferences

The Allergy Centre of the Charité-Universitätsmedizin Berlin will host three international scientific conferences in the upcoming week. According to Prof. Marcus Maurer, Associate Director of the Allergy Centre at the Clinic for Dermatology, Venereology and Allergology: "Allergological issues have been gaining in importance among clinical physicians." Prof. Mauer explains that all three conferences are focused on enabling scientific exchange about basic allergy research: "Our intent is to offer clinical physicians the opportunity to learn something about the cells, the basis for allergological illnesses.

Read more Medical News

› Verified 7 days ago

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Dr Gregory Alan Compton allows following entities to bill medicare on his behalf.
Entity NameUniversity Medical Associates Of The Medical University Of South Carol
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1043241110
PECOS PAC ID: 6305758574
Enrollment ID: O20031105000291

News Archive

Columbia Laboratories' Board of Directors set a ratio of 1-for-8 for its reverse stock split

Columbia Laboratories, Inc. ("Columbia" or the "Company") (NasdaqCM: CBRX) announced today that its Board of Directors (the "Board") has set a ratio of 1-for-8 for its previously approved reverse stock split of its common stock, and an anticipated effective date for the reverse stock split of the later of (i) the filing with the Secretary of the State of Delaware of a certificate of amendment with respect to the reverse stock split or (ii) August 9, 2013.

Sony Corporation, Global Fund enter into partnership to implement behavior change projects

"Sony Corporation and the Global Fund to Fight AIDS, Tuberculosis and Malaria have entered into a partnership for the implementation of behavior change projects, in which Sony provides state of the art equipment and movies and the Global Fund ensures it gets to agencies best able to reach communities most in need," a Global Fund press release states, noting, "This partnership is the first pilot case that combines pro bono and in-kind contribution."

Research consortium to receive 5.1 million euros to develop new device for breast cancer diagnosis

A large European research consortium headed by the University of Twente is to receive grants of more than five million euros, predominantly from the EU, to develop a new imaging device for the diagnosis of breast cancer.

Using molecular biomarkers to guide the choice of therapies for metastatic pancreatic cancer

A new pilot study demonstrated the feasibility of using molecular tumor markers as the basis for selecting the chemotherapeutic agents to use in patients with metastatic pancreatic cancer.

Allergy Centre of the Charité-Universitätsmedizin Berlin to host three international scientific conferences

The Allergy Centre of the Charité-Universitätsmedizin Berlin will host three international scientific conferences in the upcoming week. According to Prof. Marcus Maurer, Associate Director of the Allergy Centre at the Clinic for Dermatology, Venereology and Allergology: "Allergological issues have been gaining in importance among clinical physicians." Prof. Mauer explains that all three conferences are focused on enabling scientific exchange about basic allergy research: "Our intent is to offer clinical physicians the opportunity to learn something about the cells, the basis for allergological illnesses.

Read more Medical News

› Verified 7 days ago

Entity NameSc House Calls Inc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1518048859
PECOS PAC ID: 6800994807
Enrollment ID: O20070613000821

News Archive

Columbia Laboratories' Board of Directors set a ratio of 1-for-8 for its reverse stock split

Columbia Laboratories, Inc. ("Columbia" or the "Company") (NasdaqCM: CBRX) announced today that its Board of Directors (the "Board") has set a ratio of 1-for-8 for its previously approved reverse stock split of its common stock, and an anticipated effective date for the reverse stock split of the later of (i) the filing with the Secretary of the State of Delaware of a certificate of amendment with respect to the reverse stock split or (ii) August 9, 2013.

Sony Corporation, Global Fund enter into partnership to implement behavior change projects

"Sony Corporation and the Global Fund to Fight AIDS, Tuberculosis and Malaria have entered into a partnership for the implementation of behavior change projects, in which Sony provides state of the art equipment and movies and the Global Fund ensures it gets to agencies best able to reach communities most in need," a Global Fund press release states, noting, "This partnership is the first pilot case that combines pro bono and in-kind contribution."

Research consortium to receive 5.1 million euros to develop new device for breast cancer diagnosis

A large European research consortium headed by the University of Twente is to receive grants of more than five million euros, predominantly from the EU, to develop a new imaging device for the diagnosis of breast cancer.

Using molecular biomarkers to guide the choice of therapies for metastatic pancreatic cancer

A new pilot study demonstrated the feasibility of using molecular tumor markers as the basis for selecting the chemotherapeutic agents to use in patients with metastatic pancreatic cancer.

Allergy Centre of the Charité-Universitätsmedizin Berlin to host three international scientific conferences

The Allergy Centre of the Charité-Universitätsmedizin Berlin will host three international scientific conferences in the upcoming week. According to Prof. Marcus Maurer, Associate Director of the Allergy Centre at the Clinic for Dermatology, Venereology and Allergology: "Allergological issues have been gaining in importance among clinical physicians." Prof. Mauer explains that all three conferences are focused on enabling scientific exchange about basic allergy research: "Our intent is to offer clinical physicians the opportunity to learn something about the cells, the basis for allergological illnesses.

Read more Medical News

› Verified 7 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Gregory Alan Compton is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Dr Gregory Alan Compton, MD
Po Box 751461,
Charlotte, NC 28275-1461

Ph: (843) 792-6200
Dr Gregory Alan Compton, MD
171 Ashley Ave,
Charleston, SC 29425-6221

Ph: (843) 792-1414

News Archive

Columbia Laboratories' Board of Directors set a ratio of 1-for-8 for its reverse stock split

Columbia Laboratories, Inc. ("Columbia" or the "Company") (NasdaqCM: CBRX) announced today that its Board of Directors (the "Board") has set a ratio of 1-for-8 for its previously approved reverse stock split of its common stock, and an anticipated effective date for the reverse stock split of the later of (i) the filing with the Secretary of the State of Delaware of a certificate of amendment with respect to the reverse stock split or (ii) August 9, 2013.

Sony Corporation, Global Fund enter into partnership to implement behavior change projects

"Sony Corporation and the Global Fund to Fight AIDS, Tuberculosis and Malaria have entered into a partnership for the implementation of behavior change projects, in which Sony provides state of the art equipment and movies and the Global Fund ensures it gets to agencies best able to reach communities most in need," a Global Fund press release states, noting, "This partnership is the first pilot case that combines pro bono and in-kind contribution."

Research consortium to receive 5.1 million euros to develop new device for breast cancer diagnosis

A large European research consortium headed by the University of Twente is to receive grants of more than five million euros, predominantly from the EU, to develop a new imaging device for the diagnosis of breast cancer.

Using molecular biomarkers to guide the choice of therapies for metastatic pancreatic cancer

A new pilot study demonstrated the feasibility of using molecular tumor markers as the basis for selecting the chemotherapeutic agents to use in patients with metastatic pancreatic cancer.

Allergy Centre of the Charité-Universitätsmedizin Berlin to host three international scientific conferences

The Allergy Centre of the Charité-Universitätsmedizin Berlin will host three international scientific conferences in the upcoming week. According to Prof. Marcus Maurer, Associate Director of the Allergy Centre at the Clinic for Dermatology, Venereology and Allergology: "Allergological issues have been gaining in importance among clinical physicians." Prof. Mauer explains that all three conferences are focused on enabling scientific exchange about basic allergy research: "Our intent is to offer clinical physicians the opportunity to learn something about the cells, the basis for allergological illnesses.

Read more News

› Verified 7 days ago


Internal Medicine Doctors in Charleston, SC

Dr. Jeffrey Peter Yourshaw, M.D.
Internal Medicine
Medicare: Accepting Medicare Assignments
Practice Location: 169 Ashley Ave, Room 202 Main Hospital Msc 333, Charleston, SC 29425
Phone: 843-876-4807    Fax: 843-876-4809
Jennifer Lee Martin, D.O.
Internal Medicine
Medicare: Not Enrolled in Medicare
Practice Location: 171 Ashley Ave, Charleston, SC 29425
Phone: 843-792-1414    
Nikko Rowe Asuncion Tabliago, MD
Internal Medicine
Medicare: Medicare Enrolled
Practice Location: 169 Ashley Ave Rm 202, Charleston, SC 29425
Phone: 843-792-2575    
Moses K Asempah, MD
Internal Medicine
Medicare: Medicare Enrolled
Practice Location: 169 Ashley Avenue, Room 202 Main Hospital Msc333, Charleston, SC 29425
Phone: 717-491-3745    
Paige Nicole Laverick, PA-C
Internal Medicine
Medicare: Medicare Enrolled
Practice Location: 171 Ashley Ave, Charleston, SC 29425
Phone: 843-792-1414    
Amit Agrawal, MD
Internal Medicine
Medicare: Accepting Medicare Assignments
Practice Location: 171 Ashley Ave, Charleston, SC 29425
Phone: 843-792-1414    
Yevgeniy Gelfand, MD
Internal Medicine
Medicare: Medicare Enrolled
Practice Location: 67 President St, Charleston, SC 29425
Phone: 843-792-0111    

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.